Page 257 - Learnwell EVS

infection and AIDS
Secondary prophylaxis
F or p atien ts w h o d evelop a sp ecific op p ortun istic in fection , in ord er to p reven t
recurren ce on ce treatm en t for the in fection is com p leted .
Infections
P n eum ocystosis
T oxop lasm osis
Isosp oriasis
P en icilliosis
H istop lasm osis
C ryp tococcal m en in gitis
Oral or oesop hageal
can d id iasis
H erp es sim p lex
212
Secondary prophylaxis Comments
A ltern ative: dapsone P O
C hildren : 2 m g/ k g on ce daily
w ithout exceed in g 1 0 0 m g/ d ay
A d ults: 1 0 0 m g on ce d aily
cotrimoxazole P O: A ltern atives:
A d ults: sulfadiazine P O: 2 g d aily
C hildren : 5 0 m g S M X + 1 0 m g + pyrimethamine P O: 2 5 m g d aily
T M P / k g on ce d aily + folinic acid P O: 2 5 to 3 0 m g
A d ults: 8 0 0 m g S M X + 1 6 0 m g w eek ly
T M P on ce d aily or
dapsone P O: 2 0 0 m g w eek ly or
5 0 m g d aily
+ pyrimethamine P O: 7 5 m g w eek ly
+ folinic acid P O: 2 5 to 3 0 m g
w eek ly
itraconazole P O:
A d ults: 2 0 0 m g on ce d aily
fluconazole P O:
C hildren : 6 m g/ k g on ce d aily
A d ults: 2 0 0 m g on ce d aily
fluconazole P O: On ly for freq uen t an d severe
C hildren : 3 to 6 m g/ k g on ce d aily recurren ces
A dults: 1 0 0 to 2 0 0 m g on ce daily
aciclovir P O: On ly for freq uen t an d severe
C hild ren un d er 2 years: recurren ces
4 0 0 m g/ d ay in 2 d ivid ed d oses
C hild ren over 2 years an d ad ults:
8 0 0 m g/ d ay in 2 d ivid ed d oses